Chemoprevention of hormone receptor-negative breast cancer: new approaches needed

被引：0
|
作者：
Brown, P. H. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(10)70758-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7 / 8
页数：2
相关论文
共 50 条
  • [11] A new hormonal therapy for estrogen receptor-negative breast cancer
    Hardin, Chelsea
    Pommier, Rodney
    Calhoun, Kristine
    Muller, Patrick
    Jackson, Terisa
    Pommier, SuEllen
    WORLD JOURNAL OF SURGERY, 2007, 31 (05) : 1041 - 1046
  • [12] Metronomic Schedule of Paclitaxel Is Effective in Hormone Receptor-Positive and Hormone Receptor-Negative Breast Cancer
    Mehta, Rita S.
    Jackson, Donna
    Schubbert, Toni
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 3067 - 3068
  • [13] Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory
    Nahleh, Zeina
    FUTURE ONCOLOGY, 2008, 4 (01) : 15 - 21
  • [14] Erratum to: Hormone Receptor-Negative Breast Cancer: Undertreatment of Patients Over 80
    Anna Weiss
    Abraham Noorbakhsh
    Christopher Tokin
    David Chang
    Sarah L. Blair
    Annals of Surgical Oncology, 2014, 21 : 785 - 785
  • [15] Metronomic Schedule of Paclitaxel Is Effective in Hormone Receptor-Positive and Hormone Receptor-Negative Breast Cancer Reply
    Hugh, Judith
    Hanson, John
    Cheang, Maggie
    Nielsen, Torsten
    Perou, Charles
    Dumontet, Charles
    Reed, John
    Krajewska, Maryla
    Treilleux, Isabelle
    Rupin, Matthieu
    Magherini, Emmanuelle
    Mackey, John
    Martin, Miguel
    Vogel, Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) : 3068 - 3069
  • [16] Estrogen Receptor-Negative Breast Cancer: New Insights into Subclassification and Targeting
    Zhao, Jean J.
    Silver, Daniel P.
    CLINICAL CANCER RESEARCH, 2009, 15 (20) : 6309 - 6310
  • [17] WSB-1 regulates the metastatic potential of hormone receptor-negative breast cancer
    Pires, Isabel
    Poujade, Flore-Anne
    Eigleman, Lisa
    Mannion, Aaren
    Beeby, Ellie
    Pickwell, Sage
    Theodosi, Andrew
    Cawthorne, Christopher
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 193 - 194
  • [18] Statins may reduce breast cancer risk, particularly hormone receptor-negative disease
    Shaveta Vinayak
    Allison W. Kurian
    Current Breast Cancer Reports, 2009, 1 (3) : 148 - 156
  • [19] Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease
    Vinayak, Shaveta
    Kurian, Allison W.
    CURRENT BREAST CANCER REPORTS, 2009, 1 (03) : 148 - 156
  • [20] An estrogen receptor-negative breast cancer subset with over expression of hormone responsive genes
    Doane, AS
    Danso, MA
    Lal, P
    Donaton, M
    Zhang, L
    Hudis, C
    Gerald, WL
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S18 - S18
12345